Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
---|---|---|---|---|---|---|---|---|
2024-09-23 | Fortress Biotech, Inc. | ROSENWALD LINDSAY...
(PRESIDENT, CEO & CHAIRMAN) |
P | Common stock, par value $0.001 | A | 763359 | $1.84 - $1.84 | $1,404,580 |
2024-07-11 | Fortress Biotech, Inc. | ROSENWALD LINDSAY...
(President, CEO & Chairman) |
P | SERIES A CUMULATIVE PERPETUAL PREFERRED STOCK | A | 5000 | $7.48 - $7.48 | $37,417 |
2024-07-10 | Fortress Biotech, Inc. | Jin David
(Chief Financial Officer) |
P | SERIES A CUMULATIVE PERPETUAL PREFERRED STOCK | A | 500 | $7.50 - $7.50 | $3,750 |
2024-07-09 | Fortress Biotech, Inc. | ROSENWALD LINDSAY...
(President, CEO & Chairman) |
P | SERIES A CUMULATIVE PERPETUAL PREFERRED STOCK | A | 5000 | $7.39 - $7.39 | $36,971 |
2024-07-08 | Fortress Biotech, Inc. | ROSENWALD LINDSAY...
(President, CEO & Chairman) |
P | SERIES A CUMULATIVE PERPETUAL PREFERRED STOCK | A | 5000 | $7.35 - $7.35 | $36,764 |
A | Grant, award or other acquisition |
C | Conversion of Derivative or Security |
D | Disposition to the issuer of issuer equity securities |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability |
G | Bona fide Gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary Transaction |
J | Other acquisition or disposition |
K | Transaction in equity swap or instrument with similar characteristics |
L | Small Acquisition |
M | Exercise or conversion of derivative security |
O | Exercise of out-of-the-money derivative security |
P | Open Market Purchase |
S | Open Market Sale |
U | Disposition pursuant to a tender of shares in a change of control transaction |
V | Transaction Voluntarily Reported |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |